1. Home
  2. ESQ vs PHAR Comparison

ESQ vs PHAR Comparison

Compare ESQ & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esquire Financial Holdings Inc.

ESQ

Esquire Financial Holdings Inc.

HOLD

Current Price

$113.65

Market Cap

941.0M

Sector

Finance

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$12.87

Market Cap

885.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESQ
PHAR
Founded
2006
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
941.0M
885.7M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
ESQ
PHAR
Price
$113.65
$12.87
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$120.33
$38.33
AVG Volume (30 Days)
91.4K
8.0K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
0.76%
N/A
EPS Growth
14.20
N/A
EPS
1.40
N/A
Revenue
N/A
N/A
Revenue This Year
$35.15
$10.04
Revenue Next Year
$39.09
$2.51
P/E Ratio
$81.14
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$90.57
$9.54
52 Week High
$119.86
$21.34

Technical Indicators

Market Signals
Indicator
ESQ
PHAR
Relative Strength Index (RSI) 56.90 46.04
Support Level $104.40 $11.88
Resistance Level $118.39 $13.61
Average True Range (ATR) 3.29 0.48
MACD 0.34 0.13
Stochastic Oscillator 58.31 73.69

Price Performance

Historical Comparison
ESQ
PHAR

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company operating as a full service commercial bank. It serves the financial needs of the litigation industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The bank offers tailored financial and payment processing solutions to the litigation community and their clients as well as dynamic and flexible payment processing solutions to small business owners. It operates in one operating segment, that of community banking.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: